Kowalska-Duplaga, K.; Kapusta, P.; Gosiewski, T.; Sroka-Oleksiak, A.; Ludwig-Słomczyńska, A.H.; Wołkow, P.P.; Fyderek, K.
Changes in the Intestinal Microbiota Are Seen Following Treatment with Infliximab in Children with Crohn’s Disease. J. Clin. Med. 2020, 9, 687.
https://doi.org/10.3390/jcm9030687
AMA Style
Kowalska-Duplaga K, Kapusta P, Gosiewski T, Sroka-Oleksiak A, Ludwig-Słomczyńska AH, Wołkow PP, Fyderek K.
Changes in the Intestinal Microbiota Are Seen Following Treatment with Infliximab in Children with Crohn’s Disease. Journal of Clinical Medicine. 2020; 9(3):687.
https://doi.org/10.3390/jcm9030687
Chicago/Turabian Style
Kowalska-Duplaga, Kinga, Przemysław Kapusta, Tomasz Gosiewski, Agnieszka Sroka-Oleksiak, Agnieszka H. Ludwig-Słomczyńska, Paweł P. Wołkow, and Krzysztof Fyderek.
2020. "Changes in the Intestinal Microbiota Are Seen Following Treatment with Infliximab in Children with Crohn’s Disease" Journal of Clinical Medicine 9, no. 3: 687.
https://doi.org/10.3390/jcm9030687
APA Style
Kowalska-Duplaga, K., Kapusta, P., Gosiewski, T., Sroka-Oleksiak, A., Ludwig-Słomczyńska, A. H., Wołkow, P. P., & Fyderek, K.
(2020). Changes in the Intestinal Microbiota Are Seen Following Treatment with Infliximab in Children with Crohn’s Disease. Journal of Clinical Medicine, 9(3), 687.
https://doi.org/10.3390/jcm9030687